FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055589 [Registered on: 24/07/2023] Trial Registered Prospectively
Last Modified On: 20/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of avoiding nidan In Acne 
Scientific Title of Study   Evaluation Of The Effect Of Nidana Parivarjana In Yuvan Pidika 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjay Kumar Singh 
Designation  Professor 
Affiliation  Rishikul Campus UAU 
Address  OPD no 21 and IPD of Rog Nidan evum vikriti vigyan department Rishikul campus Uttarakhand Ayurved University haridwar Uttaranchal India

Hardwar
UTTARANCHAL
249401
India 
Phone  7060754892  
Fax    
Email  drsanjaysingh1970@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjay Kumar Singh 
Designation  Professor 
Affiliation  Rishikul Campus UAU 
Address  OPD no 21 and IPD of Rog Nidan evum vikriti vigyan department Rishikul campus Uttarakhand Ayurved University haridwar Uttaranchal India

Hardwar
UTTARANCHAL
249401
India 
Phone  7060754892  
Fax    
Email  drsanjaysingh1970@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tanya Chadha 
Designation  PG Scholar 
Affiliation  Rishikul Campus UAU 
Address  OPD no 21 and IPD of Rog Nidan evum vikriti vigyan department Rishikul campus Uttarakhand Ayurved University haridwar Uttaranchal India

Hardwar
UTTARANCHAL
249401
India 
Phone  8218512867  
Fax    
Email  tanyachadha14@gmail.com  
 
Source of Monetary or Material Support  
Rishikul campus, UAU, Haridwar 
 
Primary Sponsor  
Name  Rishikul Campus, UAU 
Address  Rishikul Campus, UAU, Hardwar 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tanya Chadha  Rishikul Campus UAU Haridwar   OPD no 21 and IPD of Rog Nidan Evum Vikriti Vigyan department Rishikul Rishikul Campus UAU Haridwar
Hardwar
UTTARANCHAL 
8218512867

tanyachadha14@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe Uttarakhand Ayurved University Rishikul Campus Haridware  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L700||Acne vulgaris. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: nimba vati, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1000(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -koushna jal), Additional Information: -
2Comparator ArmLifestyle--Dinacarya: , Ritucarya: , Acara Rasayana:, Other:nidan privarjana, Pathya/Apathya:no, Pathya:, Apathya:
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Patient with classical clinical symptoms of Yuvan Pidika
Patient of age group 16 to 30 years
 
 
ExclusionCriteria 
Details  Patient having age below 16 and above 30
Pidika due to any other systemic disease like Prameha
Patient with other skin disorders like psoriasis leprosy atopic dermatitis etc
Patient with diabetes
Patient suffering from any chronic disorders/systemic disorders.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the aetiopathogenesis of Yuvan Pidika   1 month 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the effect of Nidana parivarjana & Nimba Vati in management of Yuvan Pidika  6 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   07/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study will be performed to evaluate the effect of nidana parivarjana in yuvan pidika. Patients fulfilling the diagnostic criteria of yuvan pidika will be taken in the study. The status of the patient will be recorded on the day of enrollment on the basis of parameters taken in the study and response of nidan parivarjana will be recorded after the completion of study. This study will assess the role of nidana parivarjana in the management of yuvan pidika. 
Close